AU2006208430A1

AU2006208430A1 - Apparatus and method for monitoring cell motility

Info

Publication number: AU2006208430A1
Application number: AU2006208430A
Authority: AU
Inventors: John S. Condeelis; Lilian Li li Soon
Original assignee: Soon Lillian; Albert Einstein College of Medicine
Current assignee: Soon Lillian; Albert Einstein College of Medicine
Priority date: 2005-01-31
Filing date: 2006-01-31
Publication date: 2006-08-03
Also published as: WO2006079185A1

Description

WO 2006/079185 PCT/AU2006/000116 Apparatus and Method for Monitoring Cell Motility Technical Field Disclosed is an apparatus and method for monitoring 5 cell motility in response to a chemical agent. Background Cell motility in response to a chemical agent is fundamentally important in many biological processes such 10 as cancer metastasis, embryogenesis and wound healing. The study of cell motility in response to specific chemical agents can lead to the identification of agents or receptors for the agents which are potential therapeutic targets for use in the treatment of wounds, cancer and 15 inflammation. For a cell to become motile there are discrete steps of detection of a chemical agent, protrusion, adhesion of the protrusion to a substrate, the release of adhesion at the posterior of the cell and contraction that pulls the 20 cell forward into the protrusion. There are many types of cells capable of motility including bacteria, protozoa, amoeba, cellular slime moulds (Dictyostelium discoideum), fungi, sperm, fibroblasts, phagocytes, cancer cells, neurons, epithelial 25 cells, endothelial cells, and cells of the immune system including mast cells, neutrophils, lymphocytes, monocytes, macrophages, leukocytes, T-cells, B-cells, eosinophils and basophils. The different cell types demonstrate variations in 30 motility. For example, neutrophils and Dictyostelium are typically fast moving and are able to maintain a direction WO 2006/079185 PCT/AU2006/000116 -2 of movement once determined even if concentrations of a chemical agent fluctuate. In contrast, cancer cells typically move 10-15 times slower than cells, such as neutrophils and Dictyostelium, and lack the ability to 5 maintain a direction of movement and will often make numerous changes in direction of movement under conditions of fluctuating concentrations of the chemical agent. The most informative way to study cell motility is through monitoring the motility cycle of a cell in 10 response to a chemical agent of interest. However, the currently available methods and apparatus for monitoring cell motility are only suitable for certain cell types such as fast moving neutrophils or leukocytes and are not adaptable for other cell types such 15 as slow moving cancer cells. Summary In one aspect, there is provided an apparatus for monitoring cell motility in response to a chemical agent 20 comprising a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with 25 the chamber for delivering the chemical agent to a portion of the cell viewing surface; wherein the fluid delivery arrangement is arranged relative to the cell viewing surface for directing the chemical agent such that, when monitoring cell motility, 30 the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion.

WO 2006/079185 PCT/AU2006/000116 -3 The apparatus may be used for monitoring any type of cell motility in response to a chemical agent. Cell motility includes, but is not limited to chemotaxis, haptotaxis, chemokinesis, motility by contact priming 5 (with substrate patterning) and invasion. The term "chemical agent" as used herein refers to any type of agent to which a cell may respond. The chemical agent may be synthetic, for example a drug or drug compound. The chemical agent may be a biological 10 factor, for example a sugar, amino acid, peptide or protein. The chemical agent may be a chemoattractant and chemorepellent or a chemotactic agent. The chamber of the apparatus may be made from any material suitable for monitoring cell motility in response 15 to a chemical agent. In one form the chamber is made from an optically transparent material suitable for use with video microscopy. For example, the chamber may be made from glass or plastic. In use, the chamber can contain a medium suitable to 20 monitoring cell motility. The medium may be a liquid medium. The medium may be a matrix. In one form the matrix is a gel. The gel may comprise collagen, fibronectin, other connective tissue matrix components, other naturally-derived and tumour-derived matrix. The 25 medium may be a buffer such as MEM, DMEM, L15, RPMI, HEPES-buffered medium. In use, the cells to be monitored are placed onto the cell viewing surface, with the cell viewing surface being arranged so as to be submersed in the medium. The 30 apparatus is suitable for monitoring any cell type. Examples of cell types that may be monitored using the apparatus include but are not limited to cancer cells, WO 2006/079185 PCT/AU2006/000116 -4 spermatozoa, bacteria, fungi, epithelial cells, neurons, endothelial cells, fibroblasts, mast cells, neutrophils, dictyostelium cells, lymphocytes, monocytes, macrophages, leukocytes, T-cells, B-cells, eosinophils, basophils and 5 combinations thereof. The fluid delivery arrangement of the apparatus can be arranged in any configuration relative to the cell viewing surface provided that the configuration is suitable for directing the chemical agent such that, when 10 monitoring cell motility, the chemical agent assumes a concentration gradient in relation to the cell viewing surface portion. In one form, the fluid delivery arrangement comprises one or more apertures arranged to release the flow of the 15 chemical agent to the medium in the vicinity of the cell viewing surface portion. In this form, the one or each aperture can have a configuration that influences a direction to the flow of chemical agent through the aperture. For example, the side wall of the one or each 20 aperture may influence a direction to the flow of chemical agent through the aperture. The apertures may be located at any position relative to the cell viewing surface portion provided they are capable of releasing the flow of the chemical agent to the 25 medium in the vicinity of the cell viewing surface portion. For example, the apertures may be located in the cell viewing surface. In another form, the fluid delivery arrangement may further comprise a barrier construction arranged relative 30 to the cell viewing surface portion such that, when a flow of chemical agent is delivered by the fluid delivery arrangement via the one or more apertures to the cell WO 2006/079185 PCT/AU2006/000116 -5 viewing surface portion, the flow interacts with the barrier construction to impart the concentration gradient. In one form, the barrier construction diverts the flow of chemical agent to impart the concentration 5 gradient. Typically, diverting the flow of chemical agent modulates any one or more of the following: the rate at which the gradient is formed; the steady-state shape of the gradient; the stability of the gradient; the steepness of the gradient. 10 The barrier can be defined by a physical means such as a dam. The barrier can be defined by a photonic means such as through optical trapping. Methods for optical trapping and other photonic means are described in, for example, Dholakia and Reece (2006) Optical 15 Micromanipulation Takes Hold, Nanotoday Vol 1(1): 18-27; Mach,P. et al. (2002) Tunable microfluidic optical fiber, Applied Physics Letters, vol. 80(23): 4294-4296. The barrier can be defined by solid-phase chemistry as described in Lim et al. (2004) Retinal Pigment Epithelial 20 Cell Behaviour is Modulated by Alterations in Focal Cell Substrate Contacts, Investigative Ophthalmology & Visual Science, vol. 45(11): 4210-4216). In one embodiment, the cell viewing surface is a platform that defines a wall in the chamber, with the wall 25 in turn defining the dam. The wall may extend across the chamber from one chamber side to the other. The fluid delivery arrangement of the apparatus may further comprise one or more conduits in fluid communication with a source for the chemical agent, one or 30 each conduit extending to one or each respective aperture. In one embodiment, the conduits are one or more channels in a substrate that each extend to a respective WO 2006/079185 PCT/AU2006/000116 -6 aperture positioned in, or in relation to, the substrate. The channels can be any dimension suitable for delivery of the chemical agent to the cell viewing surface portion. For example, the channels can be as deep as the depth of 5 view of the lowest magnification objective lenses and as wide as the width of the chamber. In one embodiment, the channels are 50tm in depth and 50pLm in width. In another embodiment, the one or each conduit is defined by a respective one or more micropipettes, with 10 each aperture being defined by an outlet of the respective micropipette. The apertures of the apparatus may be any size suitable for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a 15 concentration gradient in relation to the cell viewing surface portion. The apertures can be as wide as the width of the chamber and as narrow as 0.02pm. In one embodiment, the apertures are 1Lm in diameter. The chemical agent may be delivered to the cell 20 viewing surface portion under pressure. The chemical agent may be delivered at a constant and continuous pressure. Alternatively, the chemical agent may be delivered under pulsed pressure. The chemical agent-may be delivered at any pressure that is suitable for delivering the chemical 25 agent. For example, when the chemical agent is delivered at 0 hPa constant pressure, the chemical may diffuse freely into the medium in the chamber. When the chemical agent is delivered at 0 hPa pulsed pressure, backpressure or pressure less than 0 hPa may be applied to stop the 30 flow of chemical agent at intervals. Typically, the chemical agent is delivered at a pressure of 0 hPa or more. In one embodiment, the chemical agent is delivered WO 2006/079185 PCT/AU2006/000116 -7 at a pressure of 20hPa. In a second aspect, there is provided apparatus for monitoring cell motility in response to a chemical agent comprising 5 a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a 10 portion of the cell viewing surface, the fluid delivery arrangement comprising a barrier construction that is arranged, relative to the cell viewing surface portion, such that when a flow of chemical agent is delivered by the fluid delivery 15 arrangement to the cell viewing surface portion, the flow interacts with the barrier construction to impart a concentration gradient of the chemical agent in the medium. The barrier construction of the second aspect may be 20 defined by the aperture wall(s) or dam of the first aspect. The apparatus of the second aspect may otherwise be as defined as per the first aspect. In a third aspect, there is provided a method for monitoring cell motility in response to a chemical agent 25 in a medium, comprising the step of delivering the chemical agent to one or more cells in a manner such that, when monitoring the motility of the one or more cells, the chemical agent has assumed a concentration gradient in the medium. 30 The concentration gradient of the chemical agent can be shaped by physically directing the flow of chemical agent to the medium in the vicinity of the one or more WO 2006/079185 PCT/AU2006/000116 -8 cells. In one form, the flow of the chemical agent is directed through one or more apertures arranged in the medium. A side wall of one or each aperture may physically 5 direct the flow of the chemical agent through the aperture. In another form, the flow of chemical agent interacts with a barrier arranged in the fluid medium to physically direct the flow of the chemical agent. The barrier can be 10 defined by a dam. The method for monitoring cell motility may be performed using the apparatus as described in the first and second aspects. 15 Brief Description of Drawings Notwithstanding any other forms that may fall within the scope of the method and apparatus as defined in the Summary, specific embodiments of the method and apparatus will now be described, by way of example only, with 20 reference to the accompanying drawings in which: Figure 1A shows a perspective view of one form of the apparatus for monitoring cell motility employing a single micropipette; Figure 1B shows a side sectional view of the 25 apparatus shown in Figure 1A; Figure 2A shows a perspective view of the apparatus shown in Figure 1 employing multiple micropipettes 2a; Figure 2B shows a perspective view of the 30 apparatus shown in Figure 1 employing a micropipette 2a having a broad tip; WO 2006/079185 PCT/AU2006/000116 -9 Figure 3 shows a perspective view of another form of the apparatus for monitoring cell motility in which: Figure 3A shows a perspective view of an upper substrate 1 containing apertures la; 5 Figure 3B shows a perspective view of a lower substrate 2 containing channels 2a; Figure 3C shows a perspective view of the assembled product of surfaces 1 and 2, with superimposition of the substrates and the upper 10 apertures la and lower channels 2a; Figure 3D shows an enlarged sectional view of the apparatus shown in Figure 3C showing the relative positions of a single aperture la in the upper substrate 1, and the opening 2b of the channel 2a in the lower 15 substrate 2; Figure 3E shows an enlarged view of a single aperture of the upper substrate shown in Figure 3A, where the side walls of the aperture direct the flow of chemical agent (the concentration gradient 7 forms at 20 the rim of the aperture and its direction is generally perpendicular to the vertical flow along the walls of aperture 1b); Figure 3F shows various alternative embodiments for the configuration of aperture la; 25 Figure 3G shows a perspective view of the apparatus shown in Figure 3C incorporating a single elongate aperture; Figure 3H shows a perspective view of the apparatus shown in Figure 3C in which the alignment of 30 the aperture(s) is intermediate the channel(s) and not at the channel termini, and where the termini of the WO 2006/079185 PCT/AU2006/000116 - 10 channel(s) are sealed; and with additional aperture set(s) being provided along the length of the channel; Figure 4 shows various embodiments of the apparatus shown in Figure 3 in which: 5 Figure 4A depicts a single channel; Figure 4B depicts more than one channel; Figure 4C depicts more than one channel 2a, each housed in a sub-chamber 3; Figure 4D depicts groups of more than one channel 10 in a single sub-chamber 3; and Figure 4E depicts groups of channels where each group is housed in its own sub-chamber 3; Figure 5 shows a perspective view of another form of the apparatus for monitoring cell motility; 15 Figure 6 shows a plan view of yet another form of the apparatus for monitoring cell motility; Figure 7 shows a steady-state concentration profile of a chemical agent for the apparatus shown in Figures 1 and 2; 20 Figure 8 shows a steady-state concentration profile of a chemical agent for the apparatus shown in Figure 3; and Figure 9 shows the concentration gradient of a chemical agent at various pressures. 25 Detailed Description of Specific Embodiments Referring firstly to Figures 1, 2 and 7, one embodiment of an apparatus for monitoring cell motility is shown. This embodiment is typically employed for 30 monitoring slow moving cell types, such as cancer cells.

WO 2006/079185 PCT/AU2006/000116 - 11 The apparatus shown comprises a chamber 3 housing two optically-transparent substrates, an upper cell viewing substrate 1 and lower substrate 2 forming a floor of the chamber 3. The substrates are approximately 100 microns 5 in thickness (t). The substrates 1, 2 are bonded together either permanently or non-permanently to form a sealed unit. The wall la of the cell viewing surface 1 defines a dam extending across the chamber from one side to the other. One or more micropipettes 2a extend to an aperture 10 in the form of a distal outlet of the micropipette, which in use is positioned to abut the dam la. The outlet diameter of the micropipette is typically 0.5pm. The aperture of each micropipette can also be held in place against dam wall la via a suitable adjustable jig. 15 In use, the cells to be monitored are seeded onto an upper surface of the cell viewing substrate 1, and the chamber filled with a suitable buffer. The micropipette(s) 2a is filled with a chemical agent and then positioned at a 400 angle (0) to the dam la. The 400 angle has been found 20 to be optimal for concentration gradient generation in the apparatus depicted, but of course can and may vary with chamber variation. The micropipette(s) is lowered into the chamber 3, manoeuvred onto the upper surface of the cell viewing substrate 1, drawn over the edge, lowered to 25 a distance (H) of 17pm from the top edge of the cell viewing substrate 1 and pushed gently against the side of the wall la. Again, the 17ptm distance has been found to be optimal, but can vary. The micropipette(s) are then connected to a 30 compressor (not shown), for example a Femtojet micromanipulator 5171 (Eppendorf) compressor. The compressor produces an adjustable, continuous pressure (P) WO 2006/079185 PCT/AU2006/000116 - 12 of approximately 20 hPa. This pressure induces the flow of the chemical agent through and out of the micropipette 2a. After leaving the micropipette the flow of agent in the medium reaches the top edge of the cell viewing substrate 5 1 and, as it progresses over the edge, it has imparted thereto via the wall la and the wall edge a concentration gradient of chemical agent, which advances into the portion of the upper surface of the cell viewing substrate 1 where the cells are located. 10 The position of the micropipette 2a and the pressure at which the chemical agent is delivered as described above result in a flow of chemical agent, and a moving gradient of concentration of the agent, which is generally perpendicular to the path of the moving cells on the 15 surface of the cell viewing substrate. The concentration gradient that forms has two phases (Figure 7). The first phase spans the 17pm distance from the tip of the micropipette 2a to the upper surface of the cell viewing substrate 1. This phase typically has a high diffusion 20 rate. The second phase spans from the edge of cell viewing substrate 1 across the upper surface of the cell viewing substrate 1. This phase typically has a slower diffusion rate. Thus the dam wall la provides for the rapid establishment of a stable and steep gradient, typically 25 within 20 seconds of micropipette agent release, that results in a slow rate of diffusion of growth factors across the upper surface of the cell viewing substrate. The cell motility is typically then monitored by time-lapse video microscopy for approximately 1 hour. 30 The apparatus shown in Figures 1 and 2 may be used with a single micropipette as shown in Figures 1A and 1B, with multiple micropipettes as shown in Figure 2A, or with a broad tipped pipette as shown in Figure 2B. One WO 2006/079185 PCT/AU2006/000116 - 13 advantage of using multiple micropipettes or a broad tipped pipette is the resultant increase in the area of the concentration gradient that the cells are exposed to. This increases the number of cells that can be monitored, 5 and therefore, the throughput of an experiment. Referring now to Figures 3, 4 and 8, where like reference numerals are used to denote similar or like parts, another embodiment of the apparatus for monitoring cell motility is shown. This form is typically suitable 10 for monitoring slow moving cell types, such as cancer cells. The apparatus shown comprises a chamber 3 with two optically-transparent substrates, an upper cell viewing substrate 1, as shown in Figure 3A and a lower substrate 2 15 as shown in Figure 3B. The substrates are microfabricated to contain either apertures la or channels 2a. The substrates are then bonded together either permanently or non-permanently to form a sealed unit as shown Figure 3C. Once sealed, the cell viewing substrate 1 20 serves as a cover and to enclose the channels 2a. The cell viewing substrate 1 contains apertures la that overlay the termini of the channels 2a in the lower substrate. The channels 2a are connected to an inlet 6, which 25 connects to a compressor (not shown) and allows the delivery of a chemical agent to the cell viewing substrate 1 (Figures 3A and 3C). Figure 3D shows a detailed view of the relationship between an aperture la in the cell viewing substrate and 30 the opening 2b of a channel 2a in the lower substrate that combine to direct the chemical agent to the upper surface of the cell viewing substrate 1. The side wall of an WO 2006/079185 PCT/AU2006/000116 - 14 aperture causes the flow of the chemical agent through the aperture to form a concentration gradient 7 which then fans over the top edge of the aperture as shown in Figure 3E. Figure 8 shows the concentration profile of a chemical 5 agent obtained using the apparatus as shown in Figure 3. The apertures la and the termini of the channels 2a may be provided with various shapes, several examples of which are shown in Figure 3F. Figure 3G shows an embodiment in which the aperture la is provided in the 10 form of an elongate groove within the cell viewing substrate 1. The aperture(s) la can be positioned at more than one location along and in the cell viewing substrate relative to the channels 2a as shown in Figure 3H. The apparatus shown in Figure 3 can be modified to 15 accommodate high-throughput experiments. Figure 4 depicts alternative configurations for the apparatus, including Figure 4A: a single channel 2a within a single chamber 3; Figure 4B: multiple channels 2a within a single chamber 3; Figure 4C: multiple channels 2a within individual sub 20 chambers 3; Figure 4D: groups of two or more channels 2a within a single sub-chamber 3; and Figure 4E: groups of two or more channels 2a within individual sub-chambers 3. Figure 5 shows another embodiment of the apparatus for monitoring cell motility. Figure 5C shows the 25 assembled apparatus. Figure 5A shows an upper substrate 1 supporting a chamber 3 thereover, and with apertures la formed in the substrate. Figure 5B shows a lower substrate 2 with channels 2a defined therein. The termini 2b of the 30 channels 2a in this embodiment are triangular in shape (but could be any shape), and are 50pm wide and 50pm deep. The apertures la are 1pm in diameter. The channels can WO 2006/079185 PCT/AU2006/000116 - 15 vary from 1pm x lpm up to 50pm x 50pm in size without effecting the concentration profile. However, to avoid interaction between flow from each aperture la, the apertures are spaced on the cell viewing substrate 1 at 5 least 40pm apart, for embodiments where the channels 2a are 50pm x 50pm in size. Figure 6 shows another embodiment of the apparatus in which the chamber 3 is circular in shape and the inlet 6 from the chemical agent is located in the centre. The 10 apertures la are located around the periphery of the chamber 3 with radially extending channels 2a extending to each respective aperture la from inlet 6. Figure 7 shows the steady state concentration profile of a chemical agent formed by diverting the flow of 15 chemical agent using a barrier as described in above and in Figures 1 and 2. As can be seen from Figure 7, dam la diverts the flow of chemical agent from micropippette 2a to impart a concentration gradient. By diverting the flow of chemical agent, the rate of formation of the gradient, 20 the shape and steepness of the gradient, and/or the stability of the gradient can be modulated. Figure 9 shows the concentration profile of a chemical agent as it varies with pressure. The Figure indicates that at pressures ranging from 10,000 to 400,000 25 Nm 2 the concentration gradient of the chemical agent remains steep, dropping from a concentration of 0.000001M to OM over a 40 pm distance. It will be apparent to a person skilled in the art that while the method and apparatus have been described 30 herein in some detail for the purposes of clarity and understanding, various modifications and alterations to the embodiments described herein may be made without WO 2006/079185 PCT/AU2006/000116 - 16 departing from the scope of concept disclosed in this specification. In the claims which follow and in the preceding description, except where the context requires otherwise 5 due to express language or necessary implication, "comprise" and variations such as "comprises" or "comprising" are used in an inclusive sense (i.e. to specify the presence of the stated features but not to preclude the presence or addition of further features). 10 It is understood that a reference herein to a prior art document does not constitute an admission that the document forms part of the common general knowledge in the art in Australia or any other country.

Claims

1. Apparatus for monitoring cell motility in response to a chemical agent comprising 5 a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a 10 portion of the cell viewing surface; wherein the fluid delivery arrangement is arranged relative to the cell viewing surface for directing the chemical agent such that, when monitoring cell motility, the chemical agent assumes a concentration gradient in 15 relation to the cell viewing surface portion.

2. Apparatus according to claim 1, wherein the fluid delivery arrangement comprises one or more apertures arranged to release the flow of the chemical agent to the 20 medium in the vicinity of the cell viewing surface portion.

3. Apparatus according to claim 2, wherein the one or each aperture has a configuration that influences a direction 25 to the flow of chemical agent through the aperture.

4. Apparatus according to claim 3, wherein the side wall of the one or each aperture influences 'a direction to the flow of chemical agent through the aperture. 30 WO 2006/079185 PCT/AU2006/000116 - 18

5. Apparatus according to claim 4, wherein the apertures are located in the cell viewing surface.

6. Apparatus according to claim 2, wherein the fluid 5 delivery arrangement further comprises a barrier construction arranged relative to the cell viewing surface portion such that, when a flow of chemical agent is delivered by the fluid delivery arrangement via the one or more apertures to the cell viewing surface portion, the 10 flow interacts with the barrier construction to impart the concentration gradient.

7. Apparatus according to claim 6, wherein the barrier is defined by a physical means. 15

8. Apparatus according to claim 7, wherein the physical means is a dam.

9. Apparatus according to claim 6, wherein the barrier is 20 defined by a photonic means.

10. Apparatus according to claims 6, wherein the barrier is defined by solid-state chemistry. 25

11. Apparatus according to claim 8, wherein the cell viewing surface is a platform that defines a wall in the chamber, with the wall in turn defining the dam.

12. Apparatus according to claim 11, wherein the wall 30 extends across the chamber, from one chamber side to the WO 2006/079185 PCT/AU2006/000116 - 19 other.

13. Apparatus according to any one of the preceding claims, wherein the fluid delivery arrangement further 5 comprises one or more conduits in fluid communication with a source for the chemical agent, one or each conduit extending to one or each respective aperture.

14. Apparatus according to claim 13, wherein the conduits 10 are one or more channels in a substrate that each extend to a respective aperture positioned in, or in relation to, the substrate.

15. Apparatus according to claim 14, wherein the channels 15 are as deep as the depth of view of the lowest magnification objective lenses and as wide as the width of the chamber.

16. Apparatus according to claim 15, wherein the channels 20 are 50t in depth and 50t in width.

17. Apparatus according to claim 16, wherein the apertures in the cell viewing surface are spaced at least 40pim apart. 25

18. Apparatus according to 13, wherein one or each conduit is defined by a respective one or more micropipettes, with each aperture being defined by an outlet of the respective micropipette. 30 WO 2006/079185 PCT/AU2006/000116 - 20

19. Apparatus according to any preceding claim wherein the one or more apertures is as wide as the width of the chamber and as narrow as 0.02pm. 5

20. Apparatus according to any preceding claim wherein the one or more aperture is 1tm in diameter.

21. Apparatus according to any preceding claim wherein the chemical agent is delivered to the cell viewing 10 surface under pressure.

22. Apparatus according to claim 20 wherein the chemical agent is delivered at a pressure of OhPa or more. 15

23. Apparatus according to claim 20 wherein the chemical agent is delivered at a pressure of 20hPa.

24. Apparatus for monitoring cell motility in response to a chemical agent comprising 20 a chamber for containing a medium; a cell viewing surface arranged in the chamber so as to be submersed in the medium when in use; a fluid delivery arrangement in communication with the chamber for delivering the chemical agent to a 25 portion of the cell viewing surface, the fluid delivery arrangement comprising a barrier construction that is arranged, relative to the cell viewing surface portion, such that when a flow of chemical agent is delivered by the fluid delivery 30 arrangement to the cell viewing surface portion, the WO 2006/079185 PCT/AU2006/000116 - 21 flow interacts with the barrier construction to impart a concentration gradient of the chemical agent in the medium. 5

25. Apparatus according to claim 21, wherein the fluid delivery arrangement comprises one or more apertures arranged to release the flow of the chemical agent to the medium in the vicinity of the cell viewing surface portion. 10

26. Apparatus according to claim 25, wherein the one or each aperture has a configuration that influences a direction to the flow of chemical agent through the aperture. 15

27. Apparatus according to claim 25 or 26, wherein the barrier construction is defined by a side wall of the one or each aperture, with each side wall influencing a direction to the flow of chemical agent through the 20 aperture.

28. Apparatus according to claim 24, wherein the barrier construction is defined by a dam in the chamber. 25

29. Apparatus according to claim 28, wherein the dam is defined by a wall that subtends from the cell viewing surface in the chamber.

30. Apparatus according to any one of claims 24 to 29, 30 wherein the fluid delivery arrangement is otherwise as WO 2006/079185 PCT/AU2006/000116 - 22 defined in any one'of claims 2 to 23.

31. A method for monitoring cell motility in response to a chemical agent in a medium, comprising the step of 5 delivering the chemical agent to one or more cells in a manner such that, when monitoring the motility of the one or more cells, the chemical agent has assumed a concentration gradient in the medium. 10

32. A method according to claim 31, wherein the concentration gradient of the chemical agent is assumed by physically directing the flow of chemical agent to the medium in the vicinity of the one or more cells. 15

33. A method according to claim 31, wherein the flow of the chemical agent is physically directed through one or more apertures arranged in the medium.

34. A method according to claim 33, wherein a side wall 20 of one or each aperture physically directs the flow of the chemical agent through the aperture.

35. A method according to claim 31, wherein the flow of chemical agent interacts with a barrier arranged in the 25 fluid medium to physically direct the flow of the chemical agent.

36. A method according to claim 35, wherein the barrier is defined by a dam. 30 WO 2006/079185 PCT/AU2006/000116 - 23

37. A method according to any one of claims 31 to 36 that employs the apparatus as defined in any one of claims 1 to 27.